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Background: In this paper, an attempt has been made to explore the relationship between height and occurrence
of the non-communicable diseases such as diabetes and hypertension.
Methods: For the purpose of analysis, Bangladesh Demographic and Health Survey (BDHS), 2011 data was used.
Bivariate analysis along with a Chi-square test was performed to examine association between height and diseases.
To measure the impact of stature on diabetes and hypertension, three different logistic regression models (Model I:
considering only quartiles of height, Model II: covariates of model I along with demographic variables and Model III:
covariates of model II along with clinical variable) were considered.
Results: Occurrence of diabetes and hypertension was found to be inversely related with the height of participants. This
inverse association was statistically significant for all three models. After controlling the demographic and clinical variables
simultaneously, the odds ratio for highest quartile compared to the lowest quartile was 0.82 with 95% confidence interval
(0.69, 0.98) for diabetes; whereas it was 0.72 with 95% confidence interval (0.55, 0.95) for hypertension.
Conclusions: Findings of this paper indicate that persons with shorter stature are substantially more likely to develop
diabetes as well as hypertension. The occurrence of non-communicable diseases like diabetes and hypertension can be
reduced by controlling genetic and non-genetic (early-life and childhood) factors that may influence the height.
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A rapid increase of Non-communicable diseases (NCDs)
is becoming an alarming threat for the achievement of
global progress in the developed and developing coun-
tries. The NCDs kill more than 36 million people each
year, among them 80% of NCD death occur in low- and
middle-income countries like Bangladesh [1]. This death
toll will rise unless proper measures are taken. If the
current trend continues, by 2020, NCDs will be respon-
sible for 73% of total death and 60% of disease burden in
the developing countries [1]. The causal risk factors of
NCD risk factors operate through intermediate risk fac-
tors such as high blood pressure, elevated blood glucose
level and plasma lipid levels [2]. These are the most
prevalent risk factors around the world [3]. Generally,* Correspondence: imerfan49@yahoo.com
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unless otherwise stated.these risk factors are modifiable and preventable. There-
fore, early identification and preventive behavior for
these risk factors can reduce the risk of developing car-
diovascular disease by 80% and risk of type II diabetes
by 90% [4]. Like other developing countries, Bangladesh
is making a transition in the disease and death patterns
from communicable diseases to NCDs [5,6]. The preven-
tion and control NCDs depend on the availability of in-
formation about these diseases and the intermediate
biological biomarkers. The 2011 BDHS is the first na-
tional survey to include biomarker measurements for
blood pressure and fasting blood glucose. In this paper,
an attempt has been made to identify potential factors
associated with the occurrence of diabetes, which is
based on blood glucose level and hypertension, which is
based on blood pressure.
The association between height of respondent and dia-
betes risk has been investigated by several epidemiologicalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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as a risk factor. Height appears to be inversely related
with diabetes, however there have been contravening re-
ports about possible association of heights and diabetes
[7-11]: a positive association was found in a study [10],
whereas no association [12] or an inverse relation was
reported in others [8,11]. Also, there was an association
only in women [9] or men [13]. Hence, it would be in-
teresting to find out a relationship between height and
development of diabetes. In this paper, we try to investi-
gate this relationship in the context of Bangladesh using
BDHS 2011 data.
In a sample survey of non-communicable disease in an
urban African adult population [14] and in some other
studies [15-18], it is found that there is no association
between height and hypertension risk. It is also found
that short stature is associated with higher risk of car-
diovascular heart disease [19-22]. A U-shaped associ-
ation is found with quartiles of stature, mainly among
women [23]. The leg length has recently been identified
as a risk factor for the cardiovascular disease [24]. After
adjusting age, gender, socioeconomic status and life style
habits, longer legs were found to be associated with
lower pulse pressure and lower low-density lipoprotein
cholesterol [25]. In this paper, an attempt has also been
made to examine the association between the height and
hypertension. The potential factors that affect diabetes
and hypertension are determined as well.
Methods
Database
The study used the 2011 Bangladesh Demographic and
Health Survey (BDHS), a nationally representative sam-
ple survey of men and women of reproductive age that
provides information on childhood mortality levels, fer-
tility preferences, use of family planning methods, and
maternal, child, and newborn health. Provision of bio-
marker indices of adult male and female populations is
the special characteristic of this survey, which are instru-
mental in determining the increasing risk of NCDs. In
the 2011 BDHS survey, a subsample of women and men
age 35 years and older were eligible to participate in the
biomarker component, which included blood pressure
measurements, blood glucose testing, and height and
weight measurements. There were 4,311 women and
4,524 men age 35 and older for blood pressure and blood
glucose measurement. Among these individuals, 92 per-
cent of women and 86 percent of men took part in the
blood pressure measurement, and 89 percent of women
and 83 percent of men participated in the blood glucose
measure measurement.
In this study, the secondary data set ‘Bangladesh
Demographic and Health Survey, 2011 has been used.
This data set was collected through a collaborative effortof the National Institute of Population Research and
Training (NIPORT), ICF International (USA) and Mitra
and Associates. The written informed consent was ob-
tained from the participants prior to participation in the
study and data collection was conducted confidentially.
For this study, there is no need ethical approval since it
is based on publically available secondary data.
Definitions of diseases
The 2011 BDHS uses WHO cut-off points for measuring
fasting plasma glucose (FPG) [26]. The cut-off points
correspond to the clinical classification for normal FPG
levels, pre-diabetes and diabetes. If FPG is between
3.9 mmol/l (70 mg/dl) and 6.0 mmol/l (108 mg/dl), par-
ticipants are considered to be normal. Participants with
FPG value of 6.1-6.9 mmol/l (110–124 mg/dl) are classi-
fied as prediabetic, and individuals with FPG greater than
or equal to 7.0 mmol/l (126 mg/dl) are considered as
diabetic. In this paper, an individual is considered to be
diabetic if his/her FPG value is greater than 6.1 mmol/l
(110 mg/dl), otherwise he/she is considered to be in nor-
mal health state or non-diabetic [2].
The 2011 BDHS uses the American Heart Association
guidelines for cut-off points for blood pressure measure-
ments [27]. The cut-off points represent to the clinical clas-
sification for hypertension as they relate to the systolic and
diastolic blood pressure measurement. For the purpose of
analysis, in this paper, we divide individuals into two cat-
egories: having hypertension and not having hypertension.
An individual is said to have hypertension if his/her systolic
blood pressure is greater than 140 mmHg or his/her dia-
stolic blood pressure is greater than 90 mmHg [28].
Along with two outcome variables diabetes and hyper-
tension, we consider height as categorical variable based on
quartiles, gender (male, female), education level (no educa-
tion, primary, secondary, higher), wealth index (poorest,
poorer, middle, richer, richest), place of residence (rural,
urban), division (Dhaka, Barisal, Chittagong, Khulna,
Rajshahi, Rangpur, Shylet), body mass index (BMI) cat-
egory [thin (BMI < 18.5), normal (BMI 18.5-24.9), over-
weight (BMI > 24.9)] as determinants of these outcomes
[11-13,25,28].
To examine the relationship between different deter-
minants and having diabetes and hypertension, first we
conduct a bivariate analysis along with a Chi-square test
and then we examine the effects of covariates that are
found to be statistically significant in the bivariate ana-
lysis by fitting logistic regression model [29]. Since the
main concern of this paper is to find a relationship be-
tween height and having diabetes and hypertension, at
the stage of regression analysis, we consider three logis-
tic regression models. These are Model 1: considering
only the quartiles of height to examine the gross effect
of the height; Model II: covariate of Model I along with
Table 1 Association between selected variables and the
occurrence of diabetes with p values
Characteristics Diabetes status p value
Non-diabetes Diabetes
n (%) n (%)
Height category
Q1: (≤1.51) 854 (63.8%) 485 (36.2%) 0.037
Q2: (1.51-1.583) 865 (65.7%) 452 (34.3%)
Q3: (1.583-1.637) 906 (67.8%) 430 (32.2%)
Q4: (≥1.673) 875 (67.2%) 429 (32.9%)
Gender
Female 2543 (66.4%) 1288 (33.6%) 0.558
Male 2503 (67.0%) 1231 (33.0%)
Education level
No education 2384 (69.5%) 1047 (30.5%) <0.001
Primary 1377 (66.1%) 706 (33.9%)
Secondary 915 (65.2%) 489 (34.8%)
Higher 370 (57.2%) 277 (42.8%)
Wealth index
Poorest 929 (68.9%) 419 (31.1%) <0.001
Poorer 935 (69.1%) 418 (30.9%)
Middle 1010 (68.9%) 455 (31.1%)
Richer 1090 (68.8%) 494 (31.2%)
Richest 1082 (59.6%) 733 (40.4%)
Place of residence
Urban 1607 (64.6%) 882 (35.4%) 0.006
Rural 3439 (67.8%) 1637 (32.2%)
Division
Dhaka 929 (70.6%) 387 (29.4%) <0.001
Barisal 669 (59.8%) 450 (40.2%)
Chittagong 502 (58.0%) 364 (42.0%)
Khulna 889 (73.8%) 316 (26.2%)
Rajshahi 717 (67.1%) 351 (32.9%)
Rangpur 769 (72.0%) 299 (28.0%)
Shylet 571 (61.9%) 352 (38.1%)
BMI category
Thin 1062 (66.4%) 538 (33.6%) <0.001
Normal 2075 (69.4%) 915 (30.6%)
Overweight 310 (49.5%) 316 (50.5%)
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place of residence, division) to examine the effect of
height after controlling the demographic variables; and
Model III: covariates in Model II along with clinical
variable (BMI) to examine the effect of height after con-
trolling the demographic as well as the clinical variables.
For the purpose analysis, the SPSS for Windows (SPSS
Inc., Chicago, IL, USA) is used.
Results
Univariate analysis
The mean height of respondent is found to be 1.57
meter with standard deviation 0.091 meter. The mini-
mum and maximum heights are 1.09 and 1.87 meters,
respectively. Among the participants, 51.21% are male
and 48.79% are female. It is observed that 34.6% of par-
ticipants have no education and 32.4%, 24.2%, and 8.8%
of respondents have primary, secondary and higher edu-
cation, respectively. Most of the respondents (66.43%) are
found to reside in the rural area. The distribution of re-
spondents among the divisions Dhaka, Barisal, Chittagong,
Khulna, Rajshahi, Rangpur, Shylet are 17.12%, 11.71%,
17.11%, 13.53%, 13.46%, 13.33%, and 13.74%, respect-
ively. More than half of the participants (57.45%) are in
the normal category of BMI measurement scale. It is
found that 30.49% are thin and 12.06% are over-
weighed. Around 20% of respondents fall in the each
category of wealth index. One-third of respondents




The background characteristics of the study participants
by diabetes status are shown in Table 1. It is interesting
to observe that prevalence of diabetes increase as height
of participant decreases. Individuals who belong to the
lower quartile of height are more likely to be diabetic
compared to their counterparts. The percentage of dia-
betes is almost equal among men (33.0%) and women
(33.6%). Considering education level it can be mentioned
that if education level increases the percentage of diabetes
also increases. Among the wealth index, the richest group
has higher proportion of diabetics (40.4%) whereas the
other groups are more or less similar (around 31%). Preva-
lence of diabetes is more in urban area (35.4%) compared
to the rural area (32.2%). Among the divisions, partici-
pants from Chittagong are most likely to have diabetes
(42.0%), whereas this is least in the Rangpur division
(28.0%). It is observed that overweighed and thin partici-
pants are more prone to be diabetic than normal weighed
participants. Among the overweighed participants, the rate
of occurrence of diabetes is 50.5%, whereas it is 33.6%
and 30.6% for the thin and normal categories of BMI,respectively. Note that height of participants is significantly
associated with the occurrence of diabetes at 5% level of
significance. The associations between diabetes levels and
education level, wealth index, place of residence, division
and BMI category are found to be highly significant (at 1%
level of significance). Only gender of participant shows in-
significant association with levels of diabetes.
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The distribution of background characteristics by the
levels of hypertension is given in Table 2. Like diabetic
patients, occurrence of hypertension is inversely re-
lated with the height of patient. The rates of having
hypertension in the four quartiles of height are 32.8%,
22.4%, 16.2% and 17.4%, respectively. This association
is statistically significant with p value <0.001. UnlikeTable 2 Association between selected variables and the
occurrence of hypertension with p values
Characteristics Hypertension status p value
No hypertension Hypertension
n (%) n (%)
Height category
Q1: (≤1.51) 935 (67.2%) 456 (32.8%) <0.001
Q2: (1.51-1.583) 1068 (77.6%) 309 (22.4%)
Q3: (1.583-1.637) 1168 (83.8%) 225 (16.2%)
Q4: (≥1.673) 1138 (82.6%) 240 (17.4%)
Gender
Female 2959 (74.3%) 1022 (25.7%) <0.001
Male 3243 (83.0%) 663 (17.0%)
Education level
No education 2786 (77.6%) 804 (22.4%) 0.003
Primary 1760 (81.1%) 411 (18.9%)
Secondary 1151 (79.1%) 305 (20.9%)
Higher 505 (75.4%) 165 (24.6%)
Wealth index
Poorest 1171 (83.5%) 232 (16.5%) <0.001
Poorer 1171 (82.0%) 257 (18.0%)
Middle 1243 (81.3%) 286 (18.7%)
Richer 1267 (77.2%) 375 (22.8%)
Richest 1350 (71.6%) 535 (28.4%)
Place of residence
Urban 1940 (74.9%) 649 (25.1%) <0.001
Rural 4262 (80.4%) 1036 (19.6%)
Division
Dhaka 1045 (77.5%) 304 (22.5%) <0.001
Barisal 757 (80.8%) 180 (19.2%)
Chittagong 992 (83.8%) 192 (16.2%)
Khulna 911 (73.6%) 327 (26.4%)
Rajshahi 892 (79.9%) 225 (20.1%)
Rangpur 794 (72.4%) 302 (27.6%)
Shylet 811 (84.0%) 155 (16.0%)
BMI category
Thin 1374 (82.7%) 288 (17.3%) <0.001
Normal 2444 (78.0%) 690 (22.0%)
Overweight 441 (67.0%) 217 (33.0%)diabetes, gender of participant is significantly associ-
ated with the levels of hypertension (p value <0.001).
Female participants are more likely to have hyperten-
sion than their counterpart (25.7% versus 17.0%). The
pattern of associations between levels of hypertension
and education level, wealth index and place of resi-
dence are almost similar to the pattern of associations
observed for the occurrence of diabetes. The rate of
occurrence of hypertension significantly (p value <0.001)
changes with divisions. Participants from Rangpur are
most likely to have hypertension (27.6%), whereas this is
least in the Shylet division (16.0%). It is noticed that with
the increase of BMI, the occurrence of hypertension is sig-
nificantly increased (p value <0.001).
Regression analysis
Diabetes
One of the main purposes of this study is to examine
the effect of height of participant on the occurrence of
diabetes. For this purpose, we consider three logistic re-
gression models. The results are given in Table 3. In
Model I, only height of participants is considered to
measure the unadjusted effect of height. It is observed
that height is almost inversely related with the develop-
ment of diabetes. For example, individual who is in the
highest quartile of height are 14% less likely to develop
diabetes compared to the individual who is in the low-
est quartile of height. Odds ratios for the second and
third quartiles are found to be statistically significant
at 5% and 10% level of significance, respectively. It is
interesting to observe from Model II and Model III
that the relationship between height and developing dia-
betes is becoming strictly inversed when demographic and
clinical variables are added to the Model I. In Model II and
Model III, both odds ratios for the second and third quar-
tiles are significant at 5% level of significance. It implies that
height of participant plays an important role in developing
the diabetes as it is found statistically significant even after
controlling the demographic and clinical variables.
It is found from Model II that rate of occurring dia-
betes increases significantly with level of education and
wealth index. For individual with highest education
level, the occurrence of diabetes is 50% higher than the
individual with no education. Those who are in the
highest wealth index level are 60% more likely to have
diabetes than who are in the middle level. Place of resi-
dence is not found to have statically significant effect,
but regions have significant effects on diabetes. Similar
results are found in the model when clinical variable
BMI is added to Model II. Both thin and overweighed in-
dividuals are positively associated with the development
of diabetes than their counterpart normal weighed. These
effects are statistically significant at 5% and 1% level of
significance, respectively.
Table 3 Regression coefficients (Reg. Coef.) and odds ratios (OR) with 95% confidence intervals (95% CI) of
explanatory variables for the occurrence of diabetes obtained from logistic regression model
Model I Model II Model III
Characteristics OR (95% CI) OR (95% CI) OR (95% CI)
Height category
Q1: (≤1.51) (Ref) 1.00 1.00 1.00
Q2: (1.51-1.583) 0.92 (0.79, 1.08) 0.92 (0.78, 1.08) 0.93 (0.79, 1.10)
Q3: (1.583-1.637) 0.84 (0.71, 0.98)** 0.81 (0.68, 0.95)** 0.84 (0.71, 1.00)**
Q4: (≥1.673) 0.86 (0.74, 1.01)* 0.79 (0.67, 0.95)** 0.82 (0.69, 0.98)**
Education level
No education (Ref) 1.00 1.00
Primary 1.06 (0.92, 1.23) 1.06 (0.91, 1.23)
Secondary 1.01 (0.84, 1.21) 0.97 (0.81, 1.17)
Higher 1.5 (1.2, 1.94)*** 1.39 (1.09, 1.77)**
Wealth index
Poorest 1.12 (0.92, 1.36) 1.09 (0.89, 1.33)
Poorer 1.15 (0.95, 1.39) 1.13 (0.93, 1.37)
Middle (Ref) 1.00 1.00
Richer 1.05 (0.87, 1.27) 1.03 (0.85, 1.25)
Richest 1.6 (1.3, 1.97)*** 1.46 (1.18, 1.79)***
Place of residence
Rural (Ref) 1.00 1.00
Urban 1.06 (0.93, 1.23) 1.11 (0.96, 1.29)
Division
Dhaka (Ref) 1.00 1.00
Barisal 1.9 (1.54, 2.38)*** 1.91 (1.53, 2.39)***
Chittagong 1.7 (1.37, 2.05)*** 1.63 (1.33, 2.00)***
Khulna 0.85 (0.69, 1.05) 0.83 (0.67, 1.03)*
Rajshahi 1.24 (1.0, 1.54)*** 1.19 (0.96, 1.49)
Rangpur 0.98 (0.79, 1.21) 0.95 (0.77, 1.18)
Shylet 1.62 (1.31, 2.01)** 1.59 (1.28, 1.97)***
BMI category
Thin 1.17 (1.03, 1.34)**
Normal (Ref) 1.00
Overweight 2.09 (1.74, 2.52)***
Notes.
***p value < 0.001, **p value < 0.05, *p value < 0.10.
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To determine the potential factors associated with the
occurrence of hypertension, following the analysis for
diabetes, three logistic regression models are fitted and
the results are given in Table 4. The unadjusted effect of
height on the hypertension is statistically significant for
all three quartiles (second, third, and fourth). Like in
diabetes, it is also found that height of participant is
almost inversely related with the development of hyper-
tension. This relation remains same in the other two
models (in Model II and Model III) after adjusting fordemographic and clinical variables. In Model I, the odds
ratio (OR) for the highest quartile is found to be 0.43
with 95% confidence interval (CI) (0.36, 0.52) and this
effect is statistically significant at 1% level of significance.
The prevalence of hypertension is decreased by 57% for
those individuals who belong to the highest quartile of
height compared to individuals in the lowest quartile.
This OR is 0.74 with 95% CI (0.57, 0.97) in the Model II;
whereas it is 0.72 in the Model III with 95% CI (0.55,
0.95). It indicates that as the participant is taller, lower
would be the rate of developing the hypertension. These
Table 4 Regression coefficients (Reg. Coef.) and odds ratios (OR) with 95% confidence intervals (95% CI) of
explanatory variables for the occurrence of hypertension obtained from logistic regression model
Model I Model II Model III
Characteristics OR (95% CI) OR (95% CI) OR (95% CI)
Height category
Q1: (≤1.51) (Ref) 1.00 1.00 1.00
Q2: (1.51-1.583) 0.59 (0.50, 0.70)*** 0.89 (0.72, 1.08) 0.88 (0.72, 1.08)
Q3: (1.583-1.637) 0.39 (0.33, 0.47)*** 0.71 (0.55, 0.92)** 0.69 (0.53, 0.90)***
Q4: (≥1.673) 0.43 (0.36, 0.52)*** 0.74 (0.57, 0.97)** 0.72 (0.55, 0.95)**
Gender
Male (Ref) 1.00 1.00
Female 0.44 (0.36, 0.54)*** 0.45 (0.36, 0.56)***
Education level
No education (Ref) 1.00 1.00
Primary 0.90 (0.76, 1.07) 0.87 (0.73, 1.04)
Secondary 0.96 (0.78, 1.19) 0.92 (0.75, 1.15)
Higher 1.26 (0.96, 1.65)* 1.14 (0.87, 1.50)
Wealth index
Poorest 0.77 (0.61, 0.97)** 0.78 (0.62, 0.99)**
Poorer 0.84 (0.67, 1.05) 0.86 (0.68, 1.08)
Middle (Ref) 1.00 1.00
Richer 1.19 (0.97, 1.47) 1.14 (0.92, 1.41)
Richest 1.63 (1.3, 2.04)*** 1.5 (1.19, 1.9)***
Place of residence
Rural (Ref) 1.00 1.00
Urban 0.92 (0.79, 1.08) 0.94 (0.80, 1.11)
Division
Dhaka (Ref) 1.00 1.00
Barisal 0.82(0.63,1.06) 0.84 (0.65, 1.1)
Chittagong 0.67(0.52, 0.85)*** 0.67 (0.52, 0.86)***
Khulna 1.44(1.15, 1.79)*** 1.45 (1.16, 1.81)***
Rajshahi 0.97(0.77, 1.24) 0.98 (0.77, 1.26)
Rangpur 1.45 (1.15,1.82)*** 1.48 (1.73, 1.87)***
Shylet 0.71 (0.55, 0.92) 0.73 (0.56, 0.95)**
BMI category
Thin 0.72 (0.61, 0.85)***
Normal (Ref) 1.00
Overweight 1.33 (1.1, 1.63)***
Notes.
***p value < 0.001, **p value < 0.05, *p value < 0.10.
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risk factor for developing hypertension.
In Model II, the effects of demographic variables on
the occurrence of hypertension are also examined along
with the effect of height of respondents. It is observed
that female is less likely to have hypertension compared
to male. In this case, the OR is found to be 0.44 with95% CI (0.36, 0.54). Only higher education level is found
to have significant impact on the hypertension. The odds
of developing hypertension is 26% higher for an individ-
ual with higher education compared to an individual
with no education. It is interesting to observe that the
development of hypertension increases with the level of
wealth index. For example, ORs are 0.77 [95% CI: (0.61,
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richest groups, respectively. Like in the case of diabetes,
place of residence of respond is found to have no signifi-
cant effect on the hypertension. Individuals from Rangpur
and Khulna divisions are more prone to the hypertension
compared to individuals from other divisions. In Model
III, effect of BMI is examined controlling demographic
variables as well as height of individuals. The pattern of ef-
fects of demographic variables in Model III is same as the
pattern found in Model II. There exists a positive linear
relationship between the levels of BMI and occurrence of
hypertension. Thin is less likely [OR: 0.72; 95% CI: (0.61,
0.85)] and overweighed is more likely to have hypertension
compared to the individual with normal weight.Discussion and conclusions
The aim of this study is to find out the relationship
between height of respondent and the occurrence of
diabetes and hypertension. For this purpose, we conduct,
first, bivariate analysis and then regression analysis by
fitting three different logistic regression models. In
Model I, only the quartiles of height on individual is
considered to examine the unadjusted effect of height
on diabetes and hypertension. Effect of height is also ex-
amined in Model II by controlling demographic vari-
ables and in Model III by controlling demographic and
clinical variables. From both bivariate analysis and all
three logistic regression models, it is found that occur-
rence of diabetes and hypertension is inversely related
with the height of participants and this association is sta-
tistically significant. That is, chance of developing dia-
betes and hypertension decreases with the increase of
height of participant.
It is not clear how height is inversely related with the oc-
currence of diabetes. One of explanations of this inverse
relation is that taller individuals have more muscle mass
and muscle is the major tissue involved in uptake of glu-
cose, against the fixed glucose load of 75 grams [7]. The
dilution effect of total body water may contribute in estab-
lishing the results [7]. The possible explanations for the in-
verse relationship between height and the occurrence of
hypertension were discussed by Lawlor et al. [24]. These
are: genetic factors determining growth patterns may be
associated with hypertension [30]; coronary artery vessel
diameter increases with height and vessel with smaller di-
ameters may result in clinical disease outcome with rela-
tively smaller amounts of atherosclerosis.
Besides height of respondents, regression analyses of
large databases have shown that education level, wealth
index, place of residence, division, and body mass index
are associated with the occurrence of diabetes. Along
with the factors associated with diabetes, gender is also
associated with the occurrence of hypertension.One of the strengths of this study is the use of a nation-
wide large sample with comprehensive information on the
occurrence of diabetes and hypertension, anthropometric
and demographic variables. Anthropometric variables are
collected by using direct measurement rather than self-
reporting. This data set is collected through a reliable and
uniform procedure, which minimize the measurement
error and bias. The response rates of this study are high.
The main limitation of this paper is to use a cross-
sectional study and hence it may produce selection and
information bias. Moreover, from this study, it may not
be possible to assess the changes in the association be-
tween height and occurrence of diabetes as well as
hypertension over the time. In our It suggests that
shorter individuals may be at higher risk of metabolic
disturbance [31]. Controlling factors which may have an
influence on height could therefore result in a reduction
of NCDs such as diabetes and hypertension. study, we
only consider individuals of age 35 years or more since
in 2011 BDHS study, men and women of age 35 or older
were only considered to provide the biomarker informa-
tion. Therefore, results of this study may not be ex-
tended to the other age groups. Though the variables on
life styles such as diet, physical exercise, and smoking
are the potential confounders for the diabetes and
hypertension, these were not included in the analysis
since these are not available in the 2011 BDHS data.
The result of this study reveals the fact that there ex-
ists an inverse relationship between height and the oc-
currence of diabetes as well as hypertension. That is, the
shorter height is associated with a higher occurrence of
diabetes as well as hypertension. The height may be con-
trolled by genetic and non-genetic (early-life and child-
hood) factors [32-34]. Naturally, if most of the members
of a family are of short stature, the next generation is
likely to have short stature. But, genetic factors are en-
tirely beyond the control of human. The non-genetic
factors which may affect the height include: maternal
smoking during pregnancy, prenatal and postnatal, ill
health during childhood and adolescence, birth weight,
mental condition during childhood and adolescence.
Non-genetic factors can be controlled to some extent by
following a healthy life style from the childhood.
In future studies, a cohort should be followed with
longitudinal data collected at an early age prior to devel-
opment of illness to establish the relationship between
the stature of an individual and occurrence of non-
communicable disease. One may also take the genetic
and non-genetic factors of stature into account for fur-
ther analysis.Abbreviations
BDHS: Bangladesh Demographic and Health Survey; FPG: Fasting plasma
glucose; NCD: Non-communicable disease; WHO: World Health Organization.
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